...
首页> 外文期刊>British Journal of Cancer >Laminin |[gamma]|1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16|[ndash]|F10 mouse melanoma cells
【24h】

Laminin |[gamma]|1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16|[ndash]|F10 mouse melanoma cells

机译:层粘连蛋白|γ| 1链肽C-16(KAFDITYVRLKF)促进B16 | ndash | F10小鼠黑色素瘤细胞的迁移,MMP-9分泌和肺转移

获取原文

摘要

Laminin-1, a heterotrimer of α1, β1, and γ1 chains specific to basement membrane, promotes cell adhesion and migration, proteinase secretion and metastases of tumour cells. Several active sites on the α1 chain have been found to promote B16–F10 melanoma lung colonisation and here we have determined whether additional tumour promoting sites exist on the β1 and γ1 chains. Recently, we have identified novel cell adhesive peptides derived from laminin β1 and γ1 chains by systematic screening of synthetic peptides. Nine β1 peptides and seven γ1 peptides active for cell adhesion were tested for their effects on experimental pulmonary metastases of B16–F10 mouse melanoma cells in vivo. The most active adhesive peptide derived from the γ1 chain globular domain, C-16 (KAFDITYVRLKF), significantly enhanced pulmonary metastases of B16–F10 cells, whereas no other peptides showed enhancement. C-16 also stimulated migration of B16–F10 cells in the Boyden chamber assay in vitro. Furthermore, C-16 significantly induced the production of MMP-9 from B16–F10 cells. These results suggest that this specific laminin γ1 chain peptide has a metastasis-promoting activity and might be a new molecular target of anti-cancer treatment.
机译:Laminin-1是基底膜特有的α1,β1和γ1链的异源三聚体,可促进细胞粘附和迁移,蛋白酶分泌和肿瘤细胞转移。已发现α1链上的几个活性位点可促进B16–F10黑色素瘤肺部定植,在这里我们确定了β1和γ1链上是否存在其他肿瘤促进位点。最近,我们通过系统地筛选合成肽,鉴定了衍生自层粘连蛋白β1和γ1链的新型细胞粘附肽。测试了对细胞粘附具有活性的9种β1肽和7种γ1肽对B16–F10小鼠黑素瘤细胞体内实验性肺转移的影响。来自γ1链球状结构域的最活跃的粘附肽C-16(KAFDITYVRLKF)显着增强了B16–F10细胞的肺转移,而没有其他肽显示增强。在博伊登室试验中,C-16还刺激了B16–F10细胞的迁移。此外,C-16明显诱导了B16–F10细胞产生MMP-9。这些结果表明,这种特定的层粘连蛋白γ1链肽具有促进转移的活性,并且可能是抗癌治疗的新分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号